Exonuclease 1 (Exo1), a member of the Rad2 family of exonucleases, exhibits 5'-3' exonuclease and flap endonuclease activities. It features an N-terminal catalytic domain conserved in Rad2 family proteins. The C-terminus, predicted to be largely unstructured, facilitates protein-protein interactions. Initially discovered as a meiotic 5'-3' exonuclease in Schizosaccharomyces pombe, Exo1 is now recognized for its involvement in diverse DNA metabolism and repair pathways. These include mismatch repair, mitotic and meiotic recombination, Okazaki fragment maturation, response to UV damage, and telomere processing and maintenance. The enzyme's multifaceted roles contribute to genomic stability and the fidelity of various cellular processes related to DNA integrity and repair.
Fig. 1 Exonuclease 1 (Goellner E. M, et al. 2015).
Exo1's significance in MMR became evident through its identification as a component of Saccharomyces cerevisiae DNA MMR. Its physical interaction with MMR proteins Msh2 and Mlh1 marked Exo1 as a key player in addressing base-base and insertion/deletion mispairs arising from DNA replication errors or recombination. Despite being a vital component, Exo1's role in MMR is not strictly indispensable, showing redundancy with other proteins in the MMR pathway. This redundancy was discovered through genetic experiments and hints at the complexity of the MMR system.
Beyond MMR, Exo1 extends its influence to recombination processes. In the resection of double-stranded DNA breaks, Exo1 plays a major but redundant role, working alongside proteins like Sgs1 helicase and Dna2 nuclease. The intricate balance between Exo1 and other resection pathways underscores the complexity of DNA repair mechanisms. In meiosis, Exo1's absence in S. cerevisiae results in modest effects on spore viability and chromosome nondisjunction, revealing redundancy with other resection pathways in this context. However, in mice, Exo1 deficiency leads to sterility, emphasizing its critical role in germ cell maturation.
Exo1's versatility extends to other DNA metabolism pathways. During Okazaki fragment maturation, Exo1 seems to provide activity in rad27Δ strains, highlighting its role in maintaining genomic integrity during replication. Additionally, Exo1 participates in the repair of DNA damaged by UV light, offering an alternative pathway to the Rad2-dependent nucleotide-excision repair. Exo1's activity at uncapped telomeres further showcases its involvement in telomere maintenance, particularly in mutant backgrounds.
A deeper understanding of eukaryotic MMR systems is crucial to appreciate Exo1's role fully. Mispair recognition involves MutS homologs, such as Msh2–Msh6 and Msh2–Msh3 heterodimers, which form clamps on DNA. This recognition initiates a cascade of events, including activation of the MutL homologs, endonuclease activity, and gap filling/repair by DNA synthesis. While E. coli serves as a model for MMR, eukaryotic MMR systems share conserved steps, although the precise mechanism for strand discrimination remains less understood.
In eukaryotes, multiple MutS homologs, arising from gene duplication and specialization, form heterodimers. Msh2-Msh6 and Msh2-Msh3 complexes recognize different types of mispairs, contributing to the specificity of the MMR system. MutL homologs, primarily Mlh1-Pms1, play a central role in recruiting endonucleases for DNA cleavage. The ATPase activity of MutL homologs, coupled with the PCNA and RFC, is crucial for MMR activation.
Strand discrimination, a pivotal step in preventing mispair-induced mutations, relies on the identification of the newly synthesized DNA strand. Unlike E. coli, where DNA methylation signals strand discrimination, eukaryotes link this process to DNA replication timing. Msh6 and Msh3, components of the Msh2-Msh6 and Msh2-Msh3 complexes, interact with PCNA, providing a connection to the replication machinery. Live cell imaging reveals the temporal restriction of MMR proficiency, emphasizing the importance of replication-generated structures as potential strand discrimination signals.
The intricate landscape of DNA mismatch repair (MMR) unveils a duality in its subpathways, categorized as Exo1-independent and Exo1-dependent. In the realm of in vitro MMR reactions, Exo1's presence is nearly ubiquitous, highlighting its significance. However, the transition to in vivo scenarios introduces a layer of complexity that underscores the nuanced role of Exo1 in maintaining genome stability.
Exo1-independent MMR subpathways demonstrate a particular sensitivity to defects in the Mlh1–Pms1 endonuclease. This suggests a specialized function where the absence of Exo1 prompts a reliance on alternative mechanisms, placing an increased emphasis on the Mlh1-Pms1 endonuclease for proficient MMR. This redundancy within Exo1-independent pathways serves as a fail-safe mechanism, ensuring that the cellular machinery can adeptly address DNA mismatches even in the absence of Exo1.
Conversely, the Exo1-dependent MMR pathway unveils a more tailored interaction between Exo1 and Mlh1. This specificity in their collaboration underscores the intricacy of Exo1's contribution to MMR, implying that Exo1 plays a unique role in certain cellular contexts. The delicate balance maintained between Exo1-independent and Exo1-dependent MMR subpathways is pivotal for the fidelity and efficiency of the MMR system, allowing it to adapt dynamically to the diverse cellular environments it encounters. This adaptability ensures that the MMR machinery remains robust and effective in its mission to rectify DNA mismatches and uphold genomic integrity.
Exonuclease 1, with its multifaceted contributions to DNA metabolism pathways, emerges as a central player in maintaining genome stability. From its role in DNA mismatch repair to participation in recombination, Okazaki fragment maturation, response to UV damage, and telomere maintenance, Exo1 showcases the intricate web of interactions that safeguard the integrity of genetic information. Understanding the nuances of Exo1's functions provides valuable insights into the broader landscape of DNA repair mechanisms, offering potential avenues for targeted therapeutic interventions in conditions associated with genomic instability.
Reference
Note: If you don't receive our verification email, do the following: